Skip to main content

Day: January 5, 2026

CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF USD 1,500,000,000 Senior Non-Preferred Callable Fixed-to-Floating Rate Notes issued on January 26, 2021 (ISIN: Rule 144A: US22535WAH07 and Regulation S: US22536PAH47)

Montrouge, January 5, 2026 CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF USD 1,500,000,000 Senior Non-Preferred Callable Fixed-to-Floating Rate Notes issued on January 26, 2021 (ISIN: Rule 144A: US22535WAH07 and Regulation S: US22536PAH47)* Crédit Agricole S.A. (the “Issuer”) announces today the redemption (the “Redemption”) with effect on January 26, 2026 (the “Redemption Date”) of all of its outstanding USD 1,500,000,000 Senior Non-Preferred Callable Fixed-to-Floating Rate Notes issued on January 26, 2021 (ISIN: Rule 144A: US22535WAH07 and Regulation S: US22536PAH47) (the “Notes”) pursuant to Condition 9(a) (Redemption at the Option of the Issuer) of the terms and conditions of the Notes included in the base offering memorandum dated April 8, 2020, as supplemented by the pricing term sheet dated January 19, 2021 (together, the “Terms...

Continue reading

Civinity has completed the acquisition of the construction workforce platform Valandinis

Civinity, AB, one of the largest building maintenance and engineering solutions groups in the Baltic States, has completed the acquisition of the remaining 49% stake in Valandinis, UAB, the company operating the construction specialists’ platform Valandinis, and has become its sole shareholder. Civinity acquired a controlling stake in UAB Valandinis in January 2023 for approximately EUR 0.54 million. The remaining shares were acquired for EUR 0.72 million; the total consideration for the full buyout amounted to approximately EUR 1.26 million. Valandinis, UAB operates a platform connecting construction specialists and construction companies, enabling companies to plan human resources more flexibly and to source additional capacity quickly for specific tasks or project stages. In 2024, Valandinis, UAB generated revenue of EUR 3.69 million,...

Continue reading

Tonner Drones communicates about BSA 2025-1 deadline and CEO is increasing his shareholding

Tonner Drones communicates about BSA 2025-1 deadline and CEO is increasing his shareholding Paris, January 5, 2026, 08:00, Tonner Drones (’the Company’) is pleased to announce that CEO van den Ouden will again increase his stake in the company. In October 2025, Tonner Drones issued BSA 2025-1 (‘TDBS1’) to participants in the successfully completed capital increase. One of the participants in this capital increase was CEO Van den Ouden. Van den Ouden will exercise his 7,414,988 BSA 2025-1 for 3,707,494 shares at a price of €0.029, thereby increasing his stake in the company. Van den Ouden is already the company’s largest shareholder with a stake of over 12%. Tonner Drones advises shareholders of the maturity date for the TDBS1, January 9, 2026. The last trading day of TDBS1 will also be January 9, 2026. Investors are advised...

Continue reading

Sampo plc’s share buybacks 2 January 2026

Sampo plc, stock exchange release, 5 January 2026 at 8:30 am EET Sampo plc’s share buybacks 2 January 2026 On 2 January 2026, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                  Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  6,077 10.34 AQEU    113,197 10.32 CEUX  31,491 10.31 TQEX  127,047 10.32 XHELTOTAL 277,812 10.32  * rounded to two decimals                     On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

Continue reading

TomTom Orbis Maps to power CARIAD’s Automated Driving systems

TomTom Orbis Maps to power CARIAD’s Automated Driving systemsTomTom Orbis Maps to power CARIAD’s Automated Driving systemsAMSTERDAM, Jan. 05, 2026 (GLOBE NEWSWIRE) — TomTom (TOM2), the specialist in mapping and location technology, today announced that CARIAD, the automotive software company of the Volkswagen Group, will use TomTom’s advanced Orbis Maps as a core component of automated driving systems developed by CARIAD. TomTom Orbis Maps for automated driving (AD) will provide fundamental spatial context to amplify and enlarge the understanding that CARIAD’s systems have of their surroundings by providing highly accurate, up-to-date location information. As an additional map-based layer within the overall vehicle software stack, TomTom’s advanced maps complement onboard sensors and systems. This capability will help...

Continue reading

Nicox Announces Complete Repayment of Kreos Capital Debt and Extends Cash Runway Beyond 2027 with New Additional Financing

Press Release Nicox Announces Complete Repayment of Kreos Capital Debt and Extends Cash Runway Beyond 2027 with New Additional FinancingCompany’s position strengthened, enabling flexibility in strategic discussions All Kreos Capital secured debt repaid using cash on hand Unsecured bond financing of up to €4 million concluded with partner and shareholder, Vester Finance Cash runway extended beyond 2027January 5, 2026 – release at 7:30 am CETSophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced repayment of all secured debt and extension of its cash runway beyond 2027 with an additional unsecured financing. “The full repayment of our debt to funds and accounts managed by Kreos Capital announced today removes a number of obligations on the Company as...

Continue reading

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: On January 7, 2026, Faraday Future will Host a Stockholders’ Day, an Event Dedicated to Transparency, Execution Updates, and Long-Term Value Creation

FF and AIxC have signed a non-binding term sheet that contemplates a purchase of $10 million in FFAI common stock. If completed, AIxC notes that it intends to use the Common Stock to explore digital asset products, including potential tokenization of the purchased shares. Over the past week, the Company reached agreements with the vast majority of warrant holders to voluntarily terminate and cancel warrants exercisable for up to approximately 44.6 million shares of Common Stock.LOS ANGELES, Jan. 04, 2026 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today shared a weekly business update from YT Jia, Founder and Global Co-CEO of FF.“In the first CEO Weekly Report of 2026,...

Continue reading

SEALSQ C-Suite Visits India to Advance Post-Quantum Semiconductor Personalization Center, Quantum Investments, and Sovereign Space Capabilities

Geneva, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that its C-suite leadership, led by its Founder and Chief Executive Officer Carlos Moreira, will conduct a strategic roadshow across India in early January to accelerate the establishment of a post-quantum semiconductor personalization center and to advance collaboration on post-quantum satellite initiatives with WISeSat.Space. The roadshow, which will take place from January 5-9, 2026, with visits to Mumbai, Ahmedabad, New Delhi, Hyderabad, and Bangalore, includes high-level meetings, industrial site visits, and strategic discussions with key partners...

Continue reading

Idorsia’s JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension

Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension. JERAYGO is a new oral antihypertensive therapy – the first systemic hypertension treatment to target a new pathway in over 30 years.Allschwil, Switzerland – January 5, 2026Idorsia Ltd (SIX: IDIA) announces that Health Canada has granted marketing authorization for JERAYGO™ (aprocitentan) for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products.1 The recommended dose is 12.5 mg orally once daily. The dose can be increased to 25 mg once daily for patients tolerating the 12.5 mg dose and in need of tighter blood pressure (BP) control.1 Hypertension remains a leading global...

Continue reading

argenx Announces Leadership Transition Marking Next Evolution of Growth

Tim Van Hauwermeiren to transition from CEO to Non-Executive Director and Chairman of Board of Directors and Karen Massey to transition from COO to CEO and Executive Director January 5, 2026 7:00 a.m. CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey, current Chief Operating Officer, will transition to Chief Executive Officer and Executive Director and Tim Van Hauwermeiren, current Chief Executive Officer, will transition to non-Executive Director and Chairman of the Board of Directors. Tim will succeed Peter Verhaeghe, who is retiring from the Board of Directors after dedicated service to the company since 2008. These changes are subject to shareholder approval at...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.